Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-05-04 Sale | 2020-05-06 9:31 pm | STEMLINE THERAPEUTICS INC | STML | Francomano Robert Chief Commercial Officer | 272 | $11.51 | $3,131 | 197,658 (Direct) | View |
| 2020-03-09 Sale | 2020-03-13 9:31 pm | STEMLINE THERAPEUTICS INC | STML | Francomano Robert Chief Commercial Officer | 1,266 | $5 | $6,330 | 197,930 (Direct) | View |
| 2020-02-07 Sale | 2020-02-14 9:29 pm | STEMLINE THERAPEUTICS INC | STML | Francomano Robert Chief Commercial Officer | 5,064 | $6.72 | $34,030 | 199,196 (Direct) | View |
| 2019-12-23 Sale | 2020-01-03 5:17 pm | STEMLINE THERAPEUTICS INC | STML | Francomano Robert Chief Commercial Officer | 2,670 | $10.84 | $28,939 | 98,321 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-22 Option Award | 2024-01-25 06:02 am | N/A 2034-01-22 | SELLAS Life Sciences Group Inc. | SLS | Francomano Robert Chief Commercial Officer | 50,000 | $0 | 70,918 (Direct) | View |
| 2023-12-06 Other | 2023-12-08 4:10 pm | N/A N/A | SELLAS Life Sciences Group Inc. | SLS | Francomano Robert Chief Commercial Officer | 1,082 | $1.08 | 22,000 (Direct) | View |
| 2023-02-02 Option Award | 2023-02-03 5:14 pm | N/A 2033-02-02 | SELLAS Life Sciences Group Inc. | SLS | Francomano Robert Chief Commercial Officer | 57,000 | $0 | 57,000 (Direct) | View |
| 2022-03-14 Option Award | 2022-03-15 4:05 pm | N/A 2032-03-14 | SELLAS Life Sciences Group Inc. | SLS | Francomano Robert Chief Commercial Officer | 100,000 | $0 | 100,000 (Direct) | View |
Ownership | 2022-03-14 4:19 pm | N/A N/A | SELLAS Life Sciences Group Inc. | SLS | Francomano Robert Chief Commercial Officer | 0 | $0 | 0 (Direct) | View |
| 2020-06-10 Disposition | 2020-06-10 11:17 am | N/A 2026-09-19 | STEMLINE THERAPEUTICS INC | STML | Francomano Robert Chief Commercial Officer | 50,000 | $0 | 0 (Direct) | View |
| 2020-06-10 Equity Swap | 2020-06-10 11:17 am | N/A N/A | STEMLINE THERAPEUTICS INC | STML | Francomano Robert Chief Commercial Officer | 200,891 | $0 | 0 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-14 9:29 pm | N/A N/A | STEMLINE THERAPEUTICS INC | STML | Francomano Robert Chief Commercial Officer | 105,939 | $0 | 199,196 (Direct) | View |